In August 2012, a class action was brought on behalf of New Yorkers claiming, among other things, that the makers of pill, TA-65, which is marketed as an anti-aging supplement, “have failed to reasonably warn consumers of the potential dangerous consequences associated with TA-65 telomerase activation and malignant tumor formation.”  (Egan, et al. v. Telomerase Activation Sciences, Inc. et al., Case No. 652533/2012, S.C.N.Y.)

 


The Latest

Filters

MaxAI

Ad Alert

MaxAI

Web extension may be better at maxing out your credit card than the full capabilities of AI.

Apple Intelligence

Ad Alert

Apple Intelligence

Apple iPhone 16 users are asking Siri, where are the AI features that were touted in ads?


Show More